Compare GKOS & SKY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GKOS | SKY |
|---|---|---|
| Founded | 1998 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 4.8B |
| IPO Year | 2015 | 1994 |
| Metric | GKOS | SKY |
|---|---|---|
| Price | $141.22 | $76.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 2 |
| Target Price | ★ $126.92 | $98.50 |
| AVG Volume (30 Days) | ★ 642.1K | 383.6K |
| Earning Date | 04-29-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.18 |
| EPS | N/A | ★ 3.12 |
| Revenue | $507,442,000.00 | ★ $2,483,448,000.00 |
| Revenue This Year | $23.32 | $7.79 |
| Revenue Next Year | $27.43 | $3.10 |
| P/E Ratio | ★ N/A | $24.50 |
| Revenue Growth | ★ 32.33 | 22.65 |
| 52 Week Low | $73.16 | $59.44 |
| 52 Week High | $145.50 | $99.17 |
| Indicator | GKOS | SKY |
|---|---|---|
| Relative Strength Index (RSI) | 73.45 | 44.43 |
| Support Level | $80.14 | $72.93 |
| Resistance Level | N/A | $79.44 |
| Average True Range (ATR) | 4.95 | 2.67 |
| MACD | 1.69 | -0.26 |
| Stochastic Oscillator | 86.28 | 23.64 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Champion Homes Inc is a factory-built housing company in North America. The company is well positioned with an portfolio of manufactured and modular homes, ADUs, park-models and modular buildings for the single-family, multi-family, and other hospitality sectors. In addition to its core home building business, the company provides construction services to install and set-up factory-built homes, operates a factory-direct retail business with 72 retail locations across the United States, and operates Star Fleet Trucking, providing transportation services to the manufactured housing and other industries from several dispatch locations across the United States.